½ÃÀ庸°í¼­
»óǰÄÚµå
1594437

À½¾Ð»óóġ·á ½ÃÀå : Á¦Ç° À¯Çüº°, »óó À¯Çüº°, ÃÖÁ¾»ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Negative Pressure Wound Therapy Market by Product (Conventional NPWT, Single-Use NPWT), Wound Type (Burn Wounds, Diabetic Foot Ulcers, Pressure Ulcers), End User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 183 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

À½¾Ð»óóġ·á ½ÃÀåÀº 2023³â 46¾ï 1,000¸¸ ´Þ·¯·Î Æò°¡µÇ°í 2024³â¿¡´Â 49¾ï 5,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, CAGR 7.40%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 76¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

À½¾Ð»óóġ·á(NPWT)´Â ¹ÐºÀµÈ µå·¹½ÌÀ» ÅëÇØ »óó¿¡ Á¦¾îµÈ ÈíÀÔÀ» °¡ÇÏ¿© ü¾×°ú °¨¿°¼º ¹°ÁúÀ» Á¦°ÅÇÔÀ¸·Î½á Ä¡À¯¸¦ ÃËÁøÇÒ °ÍÀ¸·Î, º¹ÀâÇÑ »óó Ä¡·á, º´¿ø³» °¨¿°·ü °¨¼Ò, ȯÀÚ °á°ú °³¼±¿¡ ¸Å¿ì Áß¿äÇÏ¸ç º´¿ø, ¿Ü·¡ Áø·á¼Ò, Àå±â ¿ä¾ç¿ø µî ÀÇ·á ȯ°æ¿¡¼­ ÇʼöÀûÀÎ Ä¡·á¹ýÀÔ´Ï´Ù. º´¿ø, ¿Ü·¡Áø·á¼Ò, Àå±â¿ä¾ç½Ã¼³ µî ÇコÄɾî ȯ°æ¿¡¼­ ÇʼöÀûÀÔ´Ï´Ù. ÇöÀç ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀº Àα¸ °í·ÉÈ­, ´ç´¢º´°ú ºñ¸¸ÀÇ Áõ°¡, ¿Ü°ú ¼ö¼úÀÇ Áõ°¡·Î, »óó °ü¸®¿Í ¸¸¼º »óó ÇÕº´Áõ °¨¼Ò¿¡ ÀÖ¾î NPWTÀÇ Áß¿äÇÑ ¿ªÇÒÀ» °­Á¶Çϰí ÀÖ½À´Ï´Ù. ÈÞ´ë¿ë NPWT ÀåÄ¡ ¹× ÀÏȸ¿ë NPWT ÀåÄ¡¿Í °°Àº ±â¼ú ¹ßÀüÀº ½ÃÀå È®´ëÀÇ ±âȸ°¡ µÉ °ÍÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀº ÀçÅà ¹× ¿Ü·¡ ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ´ëÀÀÇϰí, ÀÇ·á ºñ¿ëÀ» Àý°¨Çϸç, ȯÀÚÀÇ Ä¡·á ÇÁ·ÎÅäÄÝ ÁؼöÀ²À» ³ôÀÏ ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª ½ÃÀåÀº NPWT Àåºñ¿Í °ü·ÃµÈ ³ôÀº ºñ¿ë, »óȯ ¹®Á¦, ±âÁ¸ µå·¹½Ì Àç·á ¹× °í¾Ð »ê¼Ò ¿ä¹ý°ú °°Àº ´ëü Ä¡·áÀÇ °¡¿ë¼º µîÀÇ ¹®Á¦¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ¶ÇÇÑ ±ÔÁ¦ ´ç±¹ÀÇ °¨½Ã°¡ °­È­µÇ°í ½ÂÀÎ ÀýÂ÷°¡ ¾ö°ÝÇØÁö¸é¼­ ½Å±â¼úÀÇ ½Å¼ÓÇÑ °³¹ß ¹× äÅÿ¡ °É¸²µ¹ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷µéÀº ¹ÌÃæÁ·µÈ ÀÓ»óÀû ¿ä±¸¸¦ ÃæÁ·½Ãų ¼ö ÀÖ´Â ºñ¿ë È¿À²ÀûÀÌ°í »ç¿ëÇϱ⠽¬¿î ¾ð¸ÞÆ® ¿Î½º Á¢Âø ¼®°í(NPWT) ½Ã½ºÅÛ °³¹ß¿¡ ÁýÁßÇÔÀ¸·Î½á ½ÃÀå ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. Àç·á ¹× ±â±â °øÇÐÀÇ Çõ½ÅÀº Ä¡·á È¿°ú¸¦ ³ôÀ̰í ȯÀÚÀÇ Æí¾ÈÇÔÀ» Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù. ÀΰøÁö´É°ú µ¥ÀÌÅÍ ºÐ¼®À» NPWT ½Ã½ºÅÛ¿¡ ÅëÇÕÇÏ´Â µ¥ ÁßÁ¡À» µÐ ¿¬±¸¸¦ ÅëÇØ ½Ç½Ã°£ ¸ð´ÏÅ͸µ°ú ¸ÂÃãÇü Ä¡·á °èȹÀÌ °¡´ÉÇØÁ® »óó °ü¸®°¡ º¸´Ù È¿À²ÀûÀ¸·Î ÀÌ·ç¾îÁú ¼ö ÀÖ½À´Ï´Ù. ÀÓ»ó½ÃÇèÀ» À§ÇØ ÀÇ·á ¼­ºñ½º Á¦°øÀÚ¿Í Çù·ÂÇÏ°í ´Ù¾çÇÑ Ä¡·á ȯ°æ¿¡¼­ ÀûÀýÇÏ°Ô »ç¿ëÇÒ ¼ö ÀÖµµ·Ï ±³À° ÇÁ·Î±×·¥À» ÁøÇàÇÔÀ¸·Î½á ½ÃÀå ÀÔÁö¸¦ Å©°Ô °­È­ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü¹ÝÀûÀ¸·Î ½ÃÀåÀº ¼ºÀåÇÒ Áغñ°¡ µÇ¾î ÀÖÁö¸¸, »õ·Î¿î ±âȸ¸¦ ÃæºÐÈ÷ Ȱ¿ëÇϰí NPWT ºÐ¾ß¿¡¼­ Àå±âÀûÀÎ ¼º°øÀ» À¯ÁöÇϱâ À§Çؼ­´Â ºñ¿ë Á¦¾àÀ» ±Øº¹Çϰí ÀÇ·á±â±â¿¡ ´ëÇÑ Á¢±Ù¼º°ú È¿À²¼ºÀ» ³ôÀÌ´Â °ÍÀÌ °è¼Ó Áß¿äÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ[2023] 46¾ï 1,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ[2024] 49¾ï 5,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ[2030] 76¾ï ´Þ·¯
CAGR(%) 7.40%

½ÃÀå ¿ªÇÐ : ºü¸£°Ô ÁøÈ­ÇÏ´Â À½¾Ð»óóġ·á ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

À½¾Ð»óóġ·á ½ÃÀåÀº ¼ö¿ä¿Í °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤, Àü·«Àû ÀÇ»ç°áÁ¤, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ¿ÏÈ­Çϰí, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ÃËÁø¿äÀÎ
    • ¸¸¼ºÁúȯ°ú ³ë·ÉÀα¸ÀÇ Áõ°¡
    • °í±Þ »óó Ä¡·á¿¡ ´ëÇÑ ³ôÀº ¼ö¿ä
    • °í·É Ãâ»ê ½Ã Á¦¿ÕÀý°³ ¼ö¼ú Áõ°¡
  • ½ÃÀå ¾ïÁ¦¿äÀÎ
    • NPWT ÀåÄ¡ÀÇ ³ôÀº ºñ¿ë
  • ½ÃÀå ±âȸ
    • °¢±¹¿¡¼­ÀÇ À¯¸®ÇÑ »óȯ Á¦µµ
    • NPWTÀÇ ¹ßÀüÀ» À§ÇÑ ¿¬±¸ °³¹ßÀÇ ÃÊÁ¡
  • ½ÃÀå °úÁ¦
    • Ä¡·á¿¡ µû¸¥ À§Çè°ú ÇÕº´Áõ

Porter's Five Forces : À½¾Ð»óóġ·á ½ÃÀåÀ» Ž»öÇϱâ À§ÇÑ Àü·« µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲÀÇ °æÀï »óȲÀ» ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®¸¦ ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : À½¾Ð»óóġ·á ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº À½¾Ð»óóġ·á ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : À½¾Ð»óóġ·á ½ÃÀåÀÇ °æÀï »óȲ ÆÄ¾Ç

À½¾Ð»óóġ·á ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­ ¹× ÅëÇÕ Ãß¼¼¸¦ ÆÄ¾ÇÇÏ¿© º¥´õ°¡ Ä¡¿­ÇÑ °æÀï¿¡¼­ ÀÚ½ÅÀÇ À§Ä¡¸¦ °­È­Çϱâ À§ÇÑ Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : À½¾Ð»óóġ·á ½ÃÀå¿¡¼­ º¥´õÀÇ ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â À½¾Ð»óóġ·á ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ : À½¾Ð»óóġ·á ½ÃÀå¿¡¼­ ¼º°øÇϱâ À§ÇÑ Àü·« ºÐ¼® ¹× ±ÇÀå »çÇ×

À½¾Ð»óóġ·á ½ÃÀå Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ȯ°æÀÇ µµÀüÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖµµ·Ï ÁغñÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï »óȲÀ» öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ÇâÈÄ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº ¾îµðÀΰ¡?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õÀÇ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå À½¾Ð»óóġ·á ½ÃÀå : Á¦Ç°º°

  • ±âÁ¸ NPWT
  • ÀÏȸ¿ë NPWT

Á¦7Àå À½¾Ð»óóġ·á ½ÃÀå : »óó Á¾·ùº°

  • È­»ó
  • ´ç´¢º´¼º Á·ºÎ±Ë¾ç
  • ¿åâ
  • Á¤¸Æ¼º ´Ù¸®±Ë¾ç

Á¦8Àå À½¾Ð»óóġ·á ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ȨÄɾî
  • º´¿ø

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ À½¾Ð»óóġ·á ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ À½¾Ð»óóġ·á ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ À½¾Ð»óóġ·á ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®
  • ¿µ±¹

Á¦12Àå °æÀï »óȲ

  • ½ÃÀå Á¡À¯À² ºÐ¼® 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • 3M Company
  • ATMOS MedizinTechnik GmbH & Co. KG
  • Cardinal Health, Inc.
  • ConvaTec Group PLC
  • Direct Healthcare Group
  • Essity AB
  • Ingersoll Rand, Inc.
  • Lohmann & Rauscher GmbH & Co. KG
  • Medela AG
  • Molnlycke Health Care AB
  • Paul Hartmann AG
  • Pensar Medical, LLC
  • Smith & Nephew PLC
  • Sunmed Medical
  • Triage Meditech Pvt. Ltd.
ksm 24.11.28

The Negative Pressure Wound Therapy Market was valued at USD 4.61 billion in 2023, expected to reach USD 4.95 billion in 2024, and is projected to grow at a CAGR of 7.40%, to USD 7.60 billion by 2030.

Negative Pressure Wound Therapy (NPWT) involves the application of controlled suction to a wound via a sealed dressing, promoting faster healing by removing fluids and infectious materials. It is crucial for treating complex wounds, reducing hospital infection rates, and improving patient outcomes, making it indispensable in healthcare settings such as hospitals, outpatient clinics, and long-term care facilities. Current market growth is driven by an aging population, increasing incidences of diabetes and obesity, and rising surgical procedures, highlighting NPWT's essential role in managing wounds and reducing chronic wound complications. Technological advancements such as portable and single-use NPWT devices present lucrative opportunities for market expansion. These innovations cater to the growing demand for home care and ambulatory services, reduce healthcare costs, and potentially increase patient adherence to treatment protocols. However, the market faces challenges such as high costs associated with NPWT devices, reimbursement issues, and the availability of alternative treatments like traditional dressings or hyperbaric oxygen therapy. Increasing regulatory scrutiny and stringent approval processes may also hinder rapid development and adoption of new technologies. Companies can seize market opportunities by focusing on developing cost-effective, user-friendly NPWT systems that address unmet clinical needs. Further innovation in materials and device engineering could enhance therapy effectiveness and improve patient comfort. Research focused on integrating artificial intelligence and data analytics into NPWT systems could provide real-time monitoring and personalized treatment plans, making wound management more efficient. Collaborating with healthcare providers for clinical trials and engaging in training programs to ensure proper utilization in various care settings can significantly boost market presence. Overall, while the market is poised for growth, overcoming cost constraints and enhancing device accessibility and efficacy remain critical to fully capitalizing on emerging opportunities and sustaining long-term market success in the NPWT sector.

KEY MARKET STATISTICS
Base Year [2023] USD 4.61 billion
Estimated Year [2024] USD 4.95 billion
Forecast Year [2030] USD 7.60 billion
CAGR (%) 7.40%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Negative Pressure Wound Therapy Market

The Negative Pressure Wound Therapy Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing cases of chronic diseases and geriatric population
    • High demand for advanced wound care
    • Increasing occurrences of cesarean sections in elderly mothers
  • Market Restraints
    • High cost of NPWT device
  • Market Opportunities
    • Favorable reimbursement coverage in various economies
    • Focused R&D efforts for the advancements in NPWT
  • Market Challenges
    • Risk and complications associated with the therapy

Porter's Five Forces: A Strategic Tool for Navigating the Negative Pressure Wound Therapy Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Negative Pressure Wound Therapy Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Negative Pressure Wound Therapy Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Negative Pressure Wound Therapy Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Negative Pressure Wound Therapy Market

A detailed market share analysis in the Negative Pressure Wound Therapy Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Negative Pressure Wound Therapy Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Negative Pressure Wound Therapy Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Negative Pressure Wound Therapy Market

A strategic analysis of the Negative Pressure Wound Therapy Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Negative Pressure Wound Therapy Market, highlighting leading vendors and their innovative profiles. These include 3M Company, ATMOS MedizinTechnik GmbH & Co. KG, Cardinal Health, Inc., ConvaTec Group PLC, Direct Healthcare Group, Essity AB, Ingersoll Rand, Inc., Lohmann & Rauscher GmbH & Co. KG, Medela AG, Molnlycke Health Care AB, Paul Hartmann AG, Pensar Medical, LLC, Smith & Nephew PLC, Sunmed Medical, and Triage Meditech Pvt. Ltd..

Market Segmentation & Coverage

This research report categorizes the Negative Pressure Wound Therapy Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Conventional NPWT and Single-Use NPWT.
  • Based on Wound Type, market is studied across Burn Wounds, Diabetic Foot Ulcers, Pressure Ulcers, and Venous Leg Ulcers.
  • Based on End User, market is studied across Homecare and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing cases of chronic diseases and geriatric population
      • 5.1.1.2. High demand for advanced wound care
      • 5.1.1.3. Increasing occurrences of cesarean sections in elderly mothers
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of NPWT device
    • 5.1.3. Opportunities
      • 5.1.3.1. Favorable reimbursement coverage in various economies
      • 5.1.3.2. Focused R&D efforts for the advancements in NPWT
    • 5.1.4. Challenges
      • 5.1.4.1. Risk and complications associated with the therapy
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Negative Pressure Wound Therapy Market, by Product

  • 6.1. Introduction
  • 6.2. Conventional NPWT
  • 6.3. Single-Use NPWT

7. Negative Pressure Wound Therapy Market, by Wound Type

  • 7.1. Introduction
  • 7.2. Burn Wounds
  • 7.3. Diabetic Foot Ulcers
  • 7.4. Pressure Ulcers
  • 7.5. Venous Leg Ulcers

8. Negative Pressure Wound Therapy Market, by End User

  • 8.1. Introduction
  • 8.2. Homecare
  • 8.3. Hospitals

9. Americas Negative Pressure Wound Therapy Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Negative Pressure Wound Therapy Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Negative Pressure Wound Therapy Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. ATMOS MedizinTechnik GmbH & Co. KG
  • 3. Cardinal Health, Inc.
  • 4. ConvaTec Group PLC
  • 5. Direct Healthcare Group
  • 6. Essity AB
  • 7. Ingersoll Rand, Inc.
  • 8. Lohmann & Rauscher GmbH & Co. KG
  • 9. Medela AG
  • 10. Molnlycke Health Care AB
  • 11. Paul Hartmann AG
  • 12. Pensar Medical, LLC
  • 13. Smith & Nephew PLC
  • 14. Sunmed Medical
  • 15. Triage Meditech Pvt. Ltd.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦